Novel minimally invasive procedures for gastroesophageal reflux disease show promising outcomes, impacting patient selection and surgical approaches.
- Esophyx and Linx provide long-lasting symptom relief, with sustained quality of life improvements for chronic GERD patients.
- Stretta shows clinically significant long-term effects on proton pump inhibitor usage and pH monitoring but has limited follow-up data.
Surgeons should consider patient characteristics, such as hiatal hernias and PPI response, when selecting these procedures.
- Muse and Refluxstop need better data for clearer clinical roles.
Review by Hansson MR, Tsoposidis A (…) Håkanson B et 4 al. in Scand J Surg